The securities discussed in Merriman Capital, Inc.'s research reports may be unsuitable for some investors depending on their specific investment objectives, financial status, risk profile, or particular needs. Investors should consider this report as only a single factor in making their investment decisions and should not rely solely on this report in evaluating whether or not to buy or sell the securities of the subject company.
Regulation Analyst Certification (Reg. AC)
All of the views expressed in this research report accurately reflect the research analyst's personal views about any and all of the subject securities or issuers. No part of the research analyst's compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by the research analyst in the subject company of this research report. Research analysts are not directly compensated for specific revenue generated by the firm's investment banking transactions/activities.
General DisclosuresMerriman Capital, Inc. expects to receive or intends to seek compensation for investment banking services for all of the companies in its research universe in the next three months. Investors should assume that Merriman Capital, Inc. is soliciting or will solicit investment banking or other business relationships from the companies covered in this report in the next three months. Security prices in this report may either reflect the previous day's closing price or an intraday price, depending on the time of distribution. Designated trademarks and brands are the property of their respective owners. Specific Disclosures Key to investment Rankings (expected total share price return inclusive of dividend reinvestment, if applicable)
- Buy: Merriman Capital, Inc. expects the stock price to appreciate 10% or more over the next 12 months. Initiate or increase position.
- Neutral: Merriman Capital, Inc. believes the stock price is fairly valued at current levels. Maintain position or take no action.
- Sell: Merriman Capital, Inc. expects the stock price to depreciate over the next 12 months. Sell or decrease position.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts